Back to top

Omnicell Inc: (OMCL)

(Market Close from NSDQ) As of Feb 27, 2015 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$35.05 USD

35.05
160,860

-0.29 (-0.82%)

Volume: 160,860

Zacks Rank : 4-Sell [?]       4  

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Omnicell Inc., provides clinical infrastructure and workflow automation solutions that enable healthcare facilities to acquire, manage, dispense, and deliver medications and supplies more effectively and efficiently.

General Information

OMNICELL INC

590 E. MIDDLEFIELD ROAD

MOUNTAIN VIEW, CA 94043

Phone: 650-251-6100

Fax: 650-251-6266

Web: http://www.omnicell.com

Email: ir@omnicell.com

Industry MEDICAL INFO SYSTEMS
Sector Medical
Fiscal Year End December
Last Reported Quarter 12/31/2014
Next EPS Date 5/7/2015

EPS Information

Current Quarter EPS Consensus Estimate 0.14
Current Year EPS Consensus Estimate 0.99
Estimated Long-Term EPS Growth Rate 17.70
Next EPS Report Date 5/7/2015

Price and Volume Information

Zacks Rank
Yesterday's Close 35.34
52 Week High 35.79
52 Week Low 25.00
Beta 0.92
20 Day Moving Average 241,537.20
Target Price Consensus 35.25

OMCL

% Price Change
4 Week 10.33
12 Week 8.74
YTD 7.00
% Price Change Relative to S&P 500
4 Week 5.66
12 Week 6.74
YTD 4.22
Share Information
Shares Outstanding (millions) 35.60
Market Capitalization (millions) 1,258.24
Short Ratio 5.82
Last Split Date NA
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) 35.88
Trailing 12 Months 36.43
PEG Ratio 2.03
EPS Growth
vs. Previous Year 40.91%
vs. Previous Quarter 40.91%
   
Sales Growth
vs. Previous Year 14.93%
vs. Previous Quarter 8.00%
   
Price Ratios
Price/Book 3.23
Price/Cash Flow 27.45
Price / Sales 2.85
ROE
12/31/14 9.42
9/30/14 8.67
6/30/14 8.95
ROA
12/31/14 6.61
9/30/14 6.10
6/30/14 6.34
Current Ratio
12/31/14 2.52
9/30/14 2.41
6/30/14 2.67
Quick Ratio
12/31/14 2.24
9/30/14 2.12
6/30/14 2.37
Operating Margin
12/31/14 8.07
9/30/14 7.49
6/30/14 7.98
Net Margin
12/31/14 6.92
9/30/14 6.61
6/30/14 7.02
Pre-Tax Margin
12/31/14 11.00
9/30/14 10.82
6/30/14 10.79
Book Value
12/31/14 10.96
9/30/14 10.56
6/30/14 10.32
Inventory Turnover
12/31/14 6.58
9/30/14 6.31
6/30/14 6.01
Debt-to-Equity
12/31/14 NA
9/30/14 0.00
6/30/14 0.00
Debt to Capital
12/31/14 NA
9/30/14 0.00
6/30/14 0.00